ATE401347T1 - Neuartiger lysophosphatidsäure-rezeptor - Google Patents

Neuartiger lysophosphatidsäure-rezeptor

Info

Publication number
ATE401347T1
ATE401347T1 AT03780842T AT03780842T ATE401347T1 AT E401347 T1 ATE401347 T1 AT E401347T1 AT 03780842 T AT03780842 T AT 03780842T AT 03780842 T AT03780842 T AT 03780842T AT E401347 T1 ATE401347 T1 AT E401347T1
Authority
AT
Austria
Prior art keywords
receptor
lysophosphatidic acid
lpa
acid receptor
novel
Prior art date
Application number
AT03780842T
Other languages
English (en)
Inventor
Takao Shimizu
Satoshi Ishii
Kyoko Noguchi
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Application granted granted Critical
Publication of ATE401347T1 publication Critical patent/ATE401347T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03780842T 2003-01-15 2003-12-17 Neuartiger lysophosphatidsäure-rezeptor ATE401347T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003007657A JP4184097B2 (ja) 2003-01-15 2003-01-15 新規リゾホスファチジン酸受容体

Publications (1)

Publication Number Publication Date
ATE401347T1 true ATE401347T1 (de) 2008-08-15

Family

ID=32709127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780842T ATE401347T1 (de) 2003-01-15 2003-12-17 Neuartiger lysophosphatidsäure-rezeptor

Country Status (7)

Country Link
US (1) US7666611B2 (de)
EP (1) EP1591454B1 (de)
JP (1) JP4184097B2 (de)
AT (1) ATE401347T1 (de)
CA (1) CA2513296C (de)
DE (1) DE60322269D1 (de)
WO (1) WO2004063224A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2042514A1 (de) * 2007-09-25 2009-04-01 Life & Brain GmbH Erhaltung des Haarwuchses und Behandlung von Haarausfall
US20110212088A1 (en) * 2010-02-26 2011-09-01 Sabbadini Roger A Anti-paf antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010877A (en) 1997-01-10 2000-01-04 Smithkline Beecham Corporation cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor
WO2002061087A2 (en) 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
JP4344519B2 (ja) * 2000-12-28 2009-10-14 旭化成ファーマ株式会社 ＮＦ−κＢ活性化遺伝子
US20030064438A1 (en) 2001-02-23 2003-04-03 Feder John N. G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof

Also Published As

Publication number Publication date
US7666611B2 (en) 2010-02-23
CA2513296A1 (en) 2004-07-29
CA2513296C (en) 2009-10-13
EP1591454B1 (de) 2008-07-16
EP1591454A1 (de) 2005-11-02
JP4184097B2 (ja) 2008-11-19
JP2004217577A (ja) 2004-08-05
EP1591454A4 (de) 2006-02-08
US20060264361A1 (en) 2006-11-23
DE60322269D1 (de) 2008-08-28
WO2004063224A1 (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
DE60309481D1 (de) Cyclische n-aroylamine als orexinrezeptorantagonisten
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
TNSN07196A1 (en) Potentiators of glutamate receptors
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
ATE349434T1 (de) Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten
MA29088B1 (fr) Composes d'indazole-carboxamide.
EA200500520A1 (ru) Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов
EA200700367A1 (ru) Новые производные 4-бензилиденпиперидина
CR8530A (es) Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
DE602005014566D1 (de) Chinolinon-carboxamid-verbindungen
ATE441646T1 (de) 5-ht4-rezeptoragonistenverbindungen
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
DK1678297T3 (da) Fremgangsmåde til fremstilling af Gamma-carboxylerede proteiner
TNSN07015A1 (en) Kynurenic acid amide derivatives as nr2b receptor antagonists
EA200401628A1 (ru) Ингибиторы пептидной деформилазы
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
ATE401347T1 (de) Neuartiger lysophosphatidsäure-rezeptor
ATE516011T1 (de) Pharmazeutische zusammensetzungen eines a2a rezeptorantagonisten
DK1893597T3 (da) AMPA-receptorpotentiatorer
DE602005019090D1 (de) Pyrrolidin-2-on-Derivate zur Verwendung als DP1-Rezeptoragonisten
SE0001373D0 (sv) NPY Y1 receptor agonists and antagonists
DK1598366T3 (da) Somatostatinanaloger
DE602004030899D1 (de) Neues screening-verfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties